When will mounjaro be generic europe?

Mounjaro (tirzepatide) will likely not have a generic in Europe for several years, because the brand’s patents and other exclusivity protections are expected to continue through the late 2020s.

That said, the exact “when it becomes generic” date in Europe can vary by country and depends on:

• Patent expiry dates (which differ by molecule/indication and jurisdiction)
• Regulatory exclusivities (e.g., supplementary protection certificates—SPCs)
• Whether a company has authorization/launch plans for specific European markets

Most practical takeaway: for most of Europe, don’t expect generics/true “generic tirzepatide” to be broadly available until around the late 2020s (not 2025–2026).

If you tell me which country in Europe you mean (UK, Germany, France, Spain, etc.) and whether you mean any cheaper alternative vs full generic tirzepatide, I can narrow the timeline more precisely.